1. Anderlini P, Ghaddar HM, Smith TL, et al. Factors predicting complete remission and subsequent disease-free survival after a second course of induction therapy in patients with acute myelogenous leukemia resistant to the first. Leukemia. 1996;10:964-969.
2. Tornebohm E, Lockner D, Paul C. A retrospective analysis of bleeding complications in 438 patients with acute leukaemia during the years 1972-1991. Eur J Haematol. 1993;50:160-167.
3. Gmür J, Burger J, Schanz U, Fehr J, Schaffner A. Safety of stringent platelet transfusion policy for patients with acute leukaemia. Lancet. 1991;338:1223-1226.
4. Rebulla P, Finazzi G, Marangoni F, et al. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. N Engl J Med. 1997;337:1870-1875.
5. Schiffer CA, Anderson KC, Bennett CL, et al, for the American Society of Clinical Oncology. Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol. 2001;19:1519-1538.